Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company that develops, licenses, manufactures, and markets a diverse range of generic and specialty pharmaceutical products. The company operates primarily through two segments: Generics and Specialty. The Generics segment focuses on creating complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across various therapeutic categories. The Specialty segment is dedicated to the development and sale of branded pharmaceutical products, particularly for central nervous system disorders, endocrinology, and parasitic infections. Notable products include Rytary for Parkinson's disease, Zomig for migraines, Emverm for parasitic infections, and Unithroid for hypothyroidism. Amneal Pharmaceuticals distributes its products through wholesalers, distributors, hospitals, and pharmacies, with operations in the United States, India, Ireland, and other international markets. Founded in 2002 and headquartered in Bridgewater, New Jersey, the company was previously known as Atlas Holdings, Inc. before rebranding in 2018.
Top Stages
5 past transactions
Saol Therapeutics
Acquisition in 2022
Saol Therapeutics is a biotech pharmaceutical company dedicated to developing medical therapies and pharmaceutical products aimed at improving the lives of underserved patients, particularly those with rare diseases and conditions affecting the Central Nervous System. The company focuses on addressing the needs of patient populations with unmet medical needs, striving to provide effective treatments for serious and often life-threatening conditions. By prioritizing the voices of patients who may otherwise be overlooked, Saol Therapeutics is committed to delivering innovative therapies that enhance healthcare options for providers and ultimately improve patient outcomes.
Puniska Healthcare
Acquisition in 2021
Puniska Healthcare is a privately owned company dedicated to the manufacture and marketing of parenteral and injectable drugs that are critical to patient care. The company focuses on producing niche, knowledge-intensive drugs within important therapeutic segments, including analgesics, anesthetics, antiemetics, and anti-infectives. Utilizing advanced sterile and aseptic techniques, along with targeted delivery systems, Puniska Healthcare aims to deliver life-saving products to patients globally. Currently, the company is in the process of establishing a large-scale, state-of-the-art manufacturing facility to enhance its production capabilities.
Kashiv Specialty
Acquisition in 2021
Kashiv Specialty is a fully integrated pharmaceutical company that specializes in the research, development, and manufacturing of innovative medicines and advanced drug delivery technologies. The company is dedicated to creating clinically differentiated specialty pharmaceutical products and has a strong focus on lifecycle management. In addition to its proprietary product development, Kashiv Specialty provides contract research and development services to other pharmaceutical clients, offering expertise in formulation, analytical development, and clinical supply manufacturing. With a commitment to improving therapeutic options through its advanced pipeline, Kashiv Specialty is positioned as a key player in the biopharmaceutical industry.
AvKARE
Acquisition in 2019
AvKARE is a family-oriented manufacturer and wholesaler of pharmaceutical products headquartered in Pulaski, Tennessee. The company specializes in a diverse range of offerings, including medical and surgical items, laboratory supplies, biologics capital equipment, and infection control products. AvKARE serves both government and commercial sectors, focusing on meeting their medicinal needs effectively. Through a commitment to its people and a clear vision of its goals, AvKARE has developed into a thriving enterprise in the pharmaceutical industry.
Epsilon Pharmaceuticals
Acquisition in 2014
Epsilon Pharmaceuticals is a Pharmaceutical Manufacturers company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.